Here are relevant reports on : parkinsons-disease-market

• Cardiac Tissue Engineering Market by Material (Scaffold, Stem cells), Product (Heart Valve, Vascular Grafts), Applications (MI,Congenital Heart Disease), End-User (Hospitals & Clinics, Academics & Research Institutes) - Global Forecast to 2029

  The global cardiac tissue engineering market, valued at US$546.8 million in 2023, stood at US$621.2 million in 2024 and is projected to advance at a resilient CAGR of 16.5% from 2024 to 2029, culminating in a forecasted valuation of US$1,333.6 million by the end of the period. This growth is driven by increased demand for regenerative medicine, advancements in 3D bioprinting, and rising cardiovascular disease prevalence.

  • Published: September 2024
  • Price: $ 4950
  • TOC Available:

• Neuroprosthetics Market by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) & Region

  The global neuroprosthetics market is expected to grow at a CAGR of 12.4%. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are the major driving factors for this market. Some of the major players operating in the neuroprosthetics market are Boston Scientific (US), LivaNova (UK), Medtronic (US), Abbott (US), Cochlear (Australia), and Second sight (US).

  • Published: January 2018
  • Price: $ 4950
  • TOC Available:

• Endoluminal Suturing Devices Market Size, Growth by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecasts to 2027

  The global endoluminal suturing devices market in terms of revenue was estimated to be worth $78 million in 2022 and is poised to reach $139 million by 2027, growing at a CAGR of 12.0% from 2022 to 2027. The prominent players in this market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

  • Published: August 2022
  • Price: $ 4950
  • TOC Available:

• Plant Breeding and CRISPR Plants Market by Type (Conventional Breeding and Biotechnological Method), Trait (Herbicide Tolerance, Disease Resistance, Yield & Grain Size Improvement, Temperature Tolerance), Technology, Application, and Region - Global Forecast to 2030

  The global plant breeding and CRISPR plants market is projected to reach USD 13.86 billion by 2030, growing at a CAGR of 9.2% during the forecast period. The report profiles key players such as Bayer AG (Germany), KWS SAAT SE & Co. KGaA (Germany), Corteva (US), BASF (Germany), UPL (India), Rijk Zwaan Zaadteelt en Zaadhandel B.V. (Netherlands), Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA. (Switzerland), Sanatech Seed Co.,Ltd. (Japan), and Pairwise (US).

  • Published: March 2025
  • Price: $ 4950
  • TOC Available:

• Gynaecology Equipment Market by Product (Gynecology Endoscopy, Endometrial Ablation, Fluid Management, Female Sterilization), Disease Type (Pelvic Organ Prolapse, Fetal Monitoring, Breast, Cervical, Endometrial), and End User - Global Forecast to 2023

  The global gynecology equipment market is expected to reach USD 668.2 million by 2023 from USD 521.1 million in 2018, growing at a CAGR of 5.1%. Increasing gynecological procedures; increasing incidence of gynecological disorders; technological advancements and research in field of gynecological; are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

  The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.

  • Published: October 2015
  • Price: $ 4950
  • TOC Available:

• North America Human Microbiome Market By Drug & Supplement (Drugs, Probiotics, Prebiotics), Disease (Infectious, Gastrointestinal, Endocrine & Metabolic Diseases), Type (BCT/FMT, LBP), End User (Hospitals, Clinics, Long-term Care) - Forecast to 2031

  North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.

  • Published: August 2026
  • Price: $ 4950
  • TOC Available:

• Hepatitis Testing Market / Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026

  The global hepatitis testing market growth is primed to transition from $2.8 billion in 2021 to $3.6 billion by 2026, showcasing a strong CAGR of 4.7%. The growth of the global market is being driven by factors such as the high burden of hepatitis, increasing blood transfusion and donations, benefits of POC instruments and kits, and awareness initiatives on hepatitis.

  • Published: November 2021
  • Price: $ 4950
  • TOC Available:

• Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

  The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.

  • Published: July 2025
  • Price: $ 4950
  • TOC Available:

• Fiber Food Ingredients Market By Type Soluble Fiber, Insoluble Fiber, Resistant Fibres, Others) By Function (Cancer Diabetes, Gastrointestinal Health, Prebiotics, Heart Disease, Weight Management) By Geography

  • Published: September 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 41 to 50 of 50